Somalia : US Intelligence Uncovers Possible Houthi-Al-Shabaab Arms Deal
Somalia : US Intelligence Uncovers Possible Houthi-Al-Shabaab Arms Deal
Source: garoweonline.com
📰 Christopher Anzalone News
Christopher Anzalone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Christopher Anzalone. Real-time updates on events, politics, business and more.
Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference based medicines that utilize the...
Christopher Anzalone Exchange Commission Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals Inc Summer Series Series Schedule
Source: marketscreener.com
Arrowhead Pharmaceuticals Inc CEO Christopher Anzalone Sells 9,952 Shares
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CEO, Christopher Anzalone, sold 9,952 shares of the company on January 2, 2024, according to a recent SEC Filing.
Source: yahoo.com
Great week for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional investors after losing 17% over the previous year
Key Insights Institutions' substantial holdings in Arrowhead Pharmaceuticals implies that they have significant...
Christopher Anzalone Blackrock Inc Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Institutional Ownership Tell Us About Arrowhead Pharmaceuticals Institutional Investors
Source: yahoo.com
Insider Sell: CEO Christopher Anzalone Sells 24,338 Shares of Arrowhead Pharmaceuticals Inc
On October 25, 2023, Christopher Anzalone, CEO of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 24,338 shares of the company.
Source: yahoo.com
Insider Sell: CEO Christopher Anzalone Sells 57,755 Shares of Arrowhead Pharmaceuticals Inc
On September 18, 2023, Christopher Anzalone, the CEO of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 57,755 shares of the company.
Arrowhead Pharmaceuticals Inc Gurufocus Value Arrowhead Pharmaceuticals Christopher Anzalone Rna Interference
Source: yahoo.com
Arrowhead Hosts R&D Day Highlighting Its Pipeline of RNAi Therapeutics
- New Clinical Data on ARO-RAGE Show Continued Dose Response with Single Inhaled Dose of 184 mg Achieving Mean Knockdown of 90% and Max of 95% - Adipose Delivery Platform Achieved Single Dose... | June 1, 2023
United States Christopher Anzalone Kira Goldberg Matthias Salathe Michael Benatar Research Development Rd Day
Source: marketscreener.com
Arrowhead Pharmaceuticals shares rise on positive interim trial results
Arrowhead Pharmaceuticals has released positive interim results from its Phase 1/2 study of its investigational therapeutic ARO-RAGE for inflammatory lung...
Source: proactiveinvestors.com
Arrowhead Licensing Deals Pay Off with $70M in Milestone Payments - Los Angeles Business Journal
Learn more about Arrowhead Pharmaceuticals receiving two payments this month (April) totaling $70 million for milestones achieved for two drug candidates that it licensed out to other major pharmaceutical companies.
Christopher Anzalone Arrowhead Pharmaceuticals Inc Takeda Pharmaceuticals Janssen Pharmaceuticals Amgen Inc Pasadena Based Arrowhead Pharmaceuticals
Source: labusinessjournal.com
'A Strong Black Woman Run This B**** Now': New York Superintendent Is Under Fire After Purported 'Anti-White' Text Messages Were Leaked; She Says They're Fake
A Black school superintendent in Staten Island, New York, is facing multiple investigations after alleged text messages were leaked between her and
Source: atlantablackstar.com